Compile Data Set for Download or QSAR
maximum 50k data
Found 90 with Last Name = 'matelich' and Initial = 'mc'
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178014(CHEMBL370164 | N-(4-chlorophenyl)-2-(5-phenyl-7-(5...)
Affinity DataIC50:  0.200nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174602((4R,5R,6S)-5-[4-(4-Fluoro-phenylamino)-5-phenyl-py...)
Affinity DataIC50:  0.300nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134740((1R,4S,5R)-2-Hydroxymethyl-5-(5-phenyl-4-phenylami...)
Affinity DataIC50:  0.470nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090887((1R,4S,5R)-2-Methyl-5-(5-phenyl-4-phenylamino-pyrr...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against Human Recombinant Adenosine KinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178015(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178003(CHEMBL370011 | N-cyclopropyl-2-(5-phenyl-7-(5-deox...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090887((1R,4S,5R)-2-Methyl-5-(5-phenyl-4-phenylamino-pyrr...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090887((1R,4S,5R)-2-Methyl-5-(5-phenyl-4-phenylamino-pyrr...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178007(2-(5-phenyl-7-(beta-D-erythrofuranosyl)-pyrrolo[2,...)
Affinity DataIC50:  0.600nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134753((1R,4S,5R)-2-Methyl-5-(5-phenyl-4-phenylamino-pyrr...)
Affinity DataIC50:  0.800nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090883((1R,4S,5R)-2-Hydroxymethyl-5-(5-phenyl-4-phenylami...)
Affinity DataIC50:  0.800nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178023(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  0.800nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178018(2-(3-phenyl-1-(beta-D-ribofuranosyl)-pyrazolo[3,4-...)
Affinity DataIC50:  0.900nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174603((1R,2R,3R)-2-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-yl...)
Affinity DataIC50:  1nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090881((2R,3R,4S,5R)-2-(6-Bromo-5-phenyl-4-phenylamino-py...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against Human Recombinant Adenosine KinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178027(CHEMBL438449 | N-cyclopentyl-2-(5-phenyl-7-(5-deox...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178019(CHEMBL370654 | N-cyclobutyl-2-(5-phenyl-7-(5-deoxy...)
Affinity DataIC50:  1.30nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178013(CHEMBL372796 | N1-cyclopropyl-N2-(5-phenyl-7-(5-de...)
Affinity DataIC50:  1.30nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090895((2R,3R,4S,5R)-2-[4-(4-Fluoro-phenylamino)-5-phenyl...)
Affinity DataIC50:  1.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174594((1R,2R,3R)-2-[4-(3-Ethoxy-phenylamino)-5-phenyl-py...)
Affinity DataIC50:  2nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178005(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177990(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174591(4-[7-((1R,2R,3R)-3,4-Dihydroxy-tetrahydro-furan-2-...)
Affinity DataIC50:  2nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178010(4-N-(N-cyclopropylcarbamoylmethyl)amino-5-phenyl-7...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178008(CHEMBL198635 | N-cyclopropyl-2-(5-phenyl-7-(beta-D...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174599((1R,2R,3R)-2-[4-(4-Ethoxy-phenylamino)-5-phenyl-py...)
Affinity DataIC50:  3nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178021(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174593((1R,2R,3R)-2-(5-Phenyl-4-phenylamino-pyrrolo[2,3-d...)
Affinity DataIC50:  4nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177994(4-N-(propoxycarbonyl)amino-5-phenyl-7-(5-deoxy-bet...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174598((1R,2R,3R)-2-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-yl...)
Affinity DataIC50:  4nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174597((1R,2R,3R)-2-[4-(4-Bromo-phenylamino)-5-phenyl-pyr...)
Affinity DataIC50:  5nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177992(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174600((1R,2R,3R)-2-[5-(4-Ethoxy-phenyl)-4-(2-methoxy-phe...)
Affinity DataIC50:  5.30nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174592((1R,2R,3R)-2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyrimid...)
Affinity DataIC50:  6nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174596((1R,2R,3R)-2-[4-(4-Fluoro-phenylamino)-5-phenyl-py...)
Affinity DataIC50:  6nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177997(CHEMBL436096 | N-cyclopropyl-2-(3-phenyl-1-(5-deox...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177998(CHEMBL381229 | N-(cyclopropylmethyl)-2-(5-phenyl-7...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174605(4-[5-(4-Chloro-phenyl)-7-((1R,2R,3R)-3,4-dihydroxy...)
Affinity DataIC50:  7nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178022(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  7nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  9nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177987(CHEMBL200457 | N-cyclopropyl-2-(3-phenyl-1-(beta-D...)
Affinity DataIC50:  10nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50174601((1R,2R,3R)-2-[5-(3-Amino-phenyl)-4-(4-fluoro-pheny...)
Affinity DataIC50:  10nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178011(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  16nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50166242((2R,3R,4S,5R)-2-[6-(2,3-Dihydro-indol-1-yl)-8-phen...)
Affinity DataIC50:  19nMAssay Description:Inhibitory activity against Human Recombinant Adenosine KinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177988(CHEMBL200196 | N-cyclopropyl-2-(5-phenyl-7-(beta-D...)
Affinity DataIC50:  20nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178004(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  25nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50042349(2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyrimidin-7-yl)-5-...)
Affinity DataIC50:  26nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177999(4-N-(3-N-methylureido)-5-phenyl-7-(5-deoxy-beta-D-...)
Affinity DataIC50:  27nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178020(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  38nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178025(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  40nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: